Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 6/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | LIPE | Q05469 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridalyl SCHEMBL29354972 | 0.93 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| Pyridalyl SCHEMBL83386 | 0.93 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL7076327 | 0.91 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL7078841 | 0.90 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL7074999 | 0.90 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL7075429 | 0.88 | KMT2A (0.36) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL7073130 | 0.86 | KMT2A (0.36) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL8409017 | 0.86 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL8409018 | 0.86 | KMT2A (0.39) | KMT2AL3MBTL1MAPK1MRGPRX4SCN9A | |
| SCHEMBL6408724 | 0.86 | MRGPRX4 (0.40) | KMT2AMRGPRX4SCN9ALIPELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1446375-B1 | DIHALOGENPROPENE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF AS PEST CONTROL AGENTS | BAYER CROPSCIENCE SA (FR) | 2008-05-14 | — | — | EP | disclosed |
| US-6949551-B2 | Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides | BAYER CROPSCIENCE S.A. (FR) | 2005-09-27 | — | — | US | disclosed |
| EP-1446375-A1 | DIHALOGENPROPENE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF AS PEST CONTROL AGENTS | Bayer CropScience S.A. (FR) | 2004-08-18 | — | — | EP | disclosed |
| US-20040029886-A1 | Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides | MERIAL, INC. | 2004-02-12 | — | — | US | disclosed |
| WO-2003042147-A1 | DIHALOGENPROPENE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF AS PEST CONTROL AGENTS | BAYER CROPSCIENCE S.A. (FR) | 2003-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029886-A1 | Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides | DDT, CBR1, CBR3 | KMT2A 2907/4885L3MBTL1 867/4885MAPK1 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.